GlassScriptPhysician profile
Shawn J Sussman
NPI 1679592182
$9,848.33
in general payments reported to CMS, 2019-2025
22 companies · $2,070 in 2025
The $2,070 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $673 · 2022: $3,484 · 2023: $951 · 2024: $2,670 · 2025: $2,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,993 · Travel and Lodging: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,993.12 |
| Travel and Lodging | $1,697.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $4,628.75 | 2021-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medical Device Business Services, INC. | $932.61 | 2024 | |
| Zimmer Biomet Holdings, INC. | $602.17 | 2024-2025 | Sternalock Blu System, Venapax, Sternalock 360 System |
| Edwards Lifesciences Corporation | $472.64 | 2022-2023 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $420.03 | 2024 | Mitraclip, Navitor |
| Medtronic, INC. | $390.14 | 2021-2025 | Corevalve Evolut R |
| Chiesi USA, INC. | $370.05 | 2021-2023 | Cleviprex, Kengreal |
| E.R. Squibb & Sons, L.L.C. | $306.98 | 2021-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $269.56 | 2021-2023 | Farxiga |
| Abiomed | $207.76 | 2024-2025 | Impella |
| Shockwave Medical, INC | $187.43 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $180.00 | 2022 | |
| Ethicon US, LLC | $161.94 | 2024-2025 | Dermabond Prineo, Surgicel Nu-Knit, Vistaseal |
| Davol INC. | $161.38 | 2025 | Arista |
| Convatec INC. | $124.99 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $122.19 | 2023 | Prevena |
| Baxter Healthcare | $119.06 | 2021 | |
| Pfizer INC. | $64.58 | 2023-2024 | |
| Angiodynamics, INC. | $43.88 | 2025 | Angiovac |
| Merck Sharp & Dohme LLC | $33.29 | 2024 | Keytruda |
| Philips North America LLC | $26.00 | 2024 | (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.90 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Sussman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.